Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic

Despite recent advances, treatment options for advanced prostate cancer (CaP) remain limited. We are pioneering approaches to treat advanced CaP that employ conditionally replication-competent oncolytic adenoviruses that simultaneously produce a systemically active cancer-specific therapeutic cytoki...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarkar, Siddik, Quinn, Bridget A., Shen, Xue-Ning, Dash, Rupesh, Das, Swadesh K., Emdad, Luni, Klibanov, Alexander L., Wang, Xiang-Yang, Pellecchia, Maurizio, Sarkar, Devanand, Fisher, Paul B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484414/
https://www.ncbi.nlm.nih.gov/pubmed/25926554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484414/
https://www.ncbi.nlm.nih.gov/pubmed/25926554

Ejemplares similares